Skip to main content
Press release August 3, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals, Inc. (ZNTL)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site